Edit Remák
Impact in
- Economics and Econometrics top 10%
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
-
- Renal cell carcinoma treatment
Papers in
-
- Economic and Financial Impacts of Cancer 9
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 3
-
- Renal cell carcinoma treatment 10
- Co-authors
- L. Brazil (1 shared paper)Claudie Charbonneau (9 shared papers)Sylvie Négrier (3 shared papers)Robert J. Motzer (2 shared papers)Sindy T. Kim (1 shared paper)Martin Price (3 shared papers)Caroline Selai (2 shared papers)Michael Trimble (2 shared papers)
- Journals
- Value in Health (10 papers)Journal of Clinical Oncology (3 papers)Current Medical Research and Opinion (2 papers)ClinicoEconomics and Outcomes Research (2 papers)Journal of Medical Economics (2 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Edit Remák
29 papers receiving 322 citations
Peers
Comparison fields: 5 of 64
- Economics and Econometrics 143
- Pulmonary and Respiratory Medicine 132
- Oncology 94
- Gastroenterology 17
- Cancer Research 43
Countries citing papers authored by Edit Remák
This map shows the geographic impact of Edit Remák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edit Remák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edit Remák more than expected).
Fields of papers citing papers by Edit Remák
This network shows the impact of papers produced by Edit Remák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edit Remák. The network helps show where Edit Remák may publish in the future.
Co-authors
The 25 scholars most cited alongside Edit Remák, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 77 | |
| 2 | 2004 | 55 | |
| 3 | 2011 | 37 | |
| 4 | 2005 | 25 | |
| 5 | 2012 | 20 | |
| 6 | 2005 | 17 | |
| 7 | 2018 | 16 | |
| 8 | 2010 | 12 | |
| 9 | 2015 | 10 | |
| 10 | 2020 | 9 | |
| 11 | 2019 | 8 | |
| 12 | 2002 | 7 | |
| 13 | 2007 | 6 | |
| 14 | 2004 | 6 | |
| 15 | 2021 | 5 | |
| 16 | Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System | 2022 | 3 |
| 17 | 2018 | 3 | |
| 18 | 2003 | 3 | |
| 19 | 2019 | 2 | |
| 20 | 2019 | 2 |
About Edit Remák
Edit Remák is a scholar working on Economics and Econometrics, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Oncology, having authored 31 papers that have together received 336 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (10 papers), Economic and Financial Impacts of Cancer (9 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Pharmaceutical Economics and Policy (3 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Economics and Econometrics (143 citations), Pulmonary and Respiratory Medicine (132 citations), Oncology (94 citations), Gastroenterology (17 citations) and Cancer Research (43 citations). Edit Remák has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include L. Brazil, Claudie Charbonneau, Sylvie Négrier, Robert J. Motzer, Sindy T. Kim, Martin Price, Caroline Selai, Michael Trimble, John Hutton and Ágnes Benedict. Their work appears in journals such as Value in Health, Journal of Clinical Oncology, Current Medical Research and Opinion, ClinicoEconomics and Outcomes Research and Journal of Medical Economics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.